Related Experiment Video
Updated: Jul 15, 2026
11:08
Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
Published on: June 22, 2012
Microfluidics for investigating vaso-occlusions in sickle cell disease
1Agricultural and Biological Engineering Department, College of Agriculture and Life Sciences, James Worth Bagley College of Engineering, Mississippi State University, Starkville, MS, USA.
Microcirculation (New York, N.Y. : 1994)
|April 5, 2017
Summary
Sickle cell disease (SCD) involves red blood cell (RBC) changes causing painful vaso-occlusive crises. Microfluidic devices offer new ways to study SCD's complex mechanisms and test treatments.
Area of Science:
- Biomedical Engineering
- Hematology
- Pathophysiology
Background:
- Sickle cell disease (SCD) originates from a mutation in the beta-globin gene, leading to hemoglobin polymerization and red blood cell (RBC) remodeling upon deoxygenation.
- This polymerization causes RBCs to adopt abnormal shapes, triggering vaso-occlusive crises (VOCs) characterized by inflammation, thrombosis, and vascular adhesion.
- The complex, not fully understood, mechanisms underlying VOCs in the microvasculature are central to SCD pathogenesis and its complications.
Purpose of the Study:
- To review microfluidic approaches for understanding sickle cell disease (SCD) pathophysiology.
- To highlight how microfluidic platforms can elucidate disease mechanisms and identify factors influencing SCD severity.
- To showcase microfluidics as a test bed for novel therapeutic strategies in SCD.
Main Methods:
- Review of microfluidic devices designed to mimic native vasculature properties.
- Analysis of how these devices capture in vivo features like cellular composition, flow dynamics, and extracellular matrix (ECM) presentation.
- Exploration of microfluidic applications in studying SCD-related vascular events.
Main Results:
- Microfluidic devices can better recapitulate the architectural and dynamic flow properties of the in vivo microvasculature compared to traditional in vitro systems.
- These platforms enable detailed investigation into the cellular and molecular interactions driving vaso-occlusions in SCD.
- The use of microfluidics facilitates the identification of key factors contributing to SCD severity.
Conclusions:
- Microfluidic technology provides a powerful tool to advance the understanding of sickle cell disease (SCD) pathophysiology.
- These platforms are crucial for dissecting the complex mechanisms of vaso-occlusion.
- Microfluidic approaches can accelerate the development and testing of effective treatments for SCD, potentially improving patient outcomes.
